Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03240679 · ClinicalTrials.gov registry record · NA
Endoscopic Mucosal Resection and Cellular Matrix
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03240679: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03240679 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03240679, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is being done to test the usefulness of extracellular matrix (ECM) a thin sheet placed over the site after endoscopic mucosal resection to promote healing of the esophagus.
Interventions
- DEVICE Acell MatriStem® Surgical Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-03-22 |
| Est. Completion | 2017-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03240679
The ClinicalTrials.gov registry entry for NCT03240679 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acell MatriStem® Surgical Matrix is the first listed.
NCT03240679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03240679 about?
NCT03240679 is a clinical study titled "Endoscopic Mucosal Resection and Cellular Matrix". This study is being done to test the usefulness of extracellular matrix (ECM) a thin sheet placed over the site after endoscopic mucosal resection to promote healing of the esophagus.
What is the current status of trial NCT03240679?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-03-22. Estimated completion is 2017-06-20.
What interventions are being tested in trial NCT03240679?
The interventions under investigation include: Acell MatriStem® Surgical Matrix (DEVICE).
Who is sponsoring clinical trial NCT03240679?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.